Gabelli & Co Investment Advisers’s Chemed CHE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-550	Closed	-$268K	–	285
2025 Q2	$268K	Buy	+550	New	+$313K	0.04%	193
2025 Q1	–	Sell	-400	Closed	-$212K	–	253
2024 Q4	$212K	Hold	400	–	–	0.04%	191
2024 Q3	$240K	Hold	400	–	–	0.04%	152
2024 Q2	$217K	Hold	400	–	–	0.04%	187
2024 Q1	$257K	Buy	+400	New	+$243K	0.04%	162
2021 Q4	–	Sell	-450	Closed	-$209K	–	496
2021 Q3	$209K	Buy	+450	New	+$212K	0.03%	341
2016 Q3	–	Sell	-2,000	Closed	-$273K	–	167
2016 Q2	$273K	Buy	+2,000	New	+$265K	0.04%	144
2015 Q3	–	Sell	-1,800	Closed	-$236K	–	167
2015 Q2	$236K	Buy	+1,800	New	+$223K	0.03%	146
2014 Q3	–	Sell	-2,750	Closed	-$258K	–	174
2014 Q2	$258K	Hold	2,750	–	–	0.06%	108
2014 Q1	$246K	Hold	2,750	–	–	0.07%	100
2013 Q4	$211K	Sell	2,750 -500	-15%	-$36.9K	0.08%	99
2013 Q3	$232K	Buy	+3,250	New	+$231K	0.05%	108

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Gabelli & Co Investment Advisers's CHE Position: Q3 2025 in Review

Gabelli & Co Investment Advisers sold out of Chemed (CHE) in Q3 2025, closing a stake of 550 shares — an estimated $268K sold.

Gabelli & Co Investment Advisers first reported a position in CHE in Q3 2013 and held it in 12 quarters. The position peaked at $273K in Q2 2016. 523 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

Gabelli & Co Investment Advisers reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 550 Chemed shares in Q3 2025, an estimated $268K.
Gabelli & Co Investment Advisers first reported a position in Chemed in Q3 2013 and held it in 12 quarters.
Gabelli & Co Investment Advisers's Chemed position peaked at $273K in Q2 2016.
523 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.